I think we will see the money come out of south florida and from better than expected sales revenue. Mullen has established an incredible establishment of elderly individuals that will be a boon for where he will take Rock Creek Pharma. TBI, Alzheimers Disease (in conjunction with Archer Pharmaceuticals), and arthritis. These 3 ailments are well within Anatabines realm of treatment (IMHO) and will have a very large source of candidates that could use it. I would love to see them also try to get a clinical trial of using Anatabine in conjunction with RCHOP for cancer treatment. I think it will work as well and most likely a lot better than the "P" (Prednisone) with out all the long term side effects. You could knock off $10,000 per chemo treatment (x4-6 treatments) if Anatabine is found to be just as effective as Prednisone. I think it would be tough to get to trials, at least until other trials show anatabines effectness and MOA.
What's happening with the company is a very good thing. Cash has always been the issue. That has never changed over the past 5 years. Now they have clear evidence to support pursuit of a potential block buster drug. Money will come, this I have no doubt. Rock Creek Pharma will have clinical trials by end of 1st quarter next year (my guess). They won't wait much longer.
My biggest fear is a buyout. JW giving up his ship sounds a little bit unusual. There is something else going on (IMO) that does not quite add up. I suppose we will know soon enough. I would not be too concerned with the share price just yet. I still think it's a huge bargain when you consider the potential growth this company could have. I can't wait for the investor meeting they are planning in early 2014. This is where the dough will come from if no one else shows up to play.
$1.25 -$1.60 sounds really good about now. I have a big bucket waiting. I suspect there will be some selling between now and tax time, unless of course good news comes out that improves share price. The potential for share price moving news? If we see it, it will be in the quarterly report. Otherwise, buy out or partnership news.
Prednisone is approved to be used to reduce inflammation and suppress (lower) the body's immune response.
It is used with other drugs to treat the following types of cancer:
Acute lymphoblastic leukemia (ALL).
Chronic lymphocytic leukemia (CLL).
Hodgkin lymphoma.
Multiple myeloma.
Mycosis fungoides.
Non-Hodgkin lymphoma.
Prostate cancer.
Thymoma and thymic carcinoma.
Prednisone is also used alone or with other drugs to prevent or treat the following conditions related to cancer:
Anemia.
Anorexia (loss of appetite caused by chemotherapy).
Drug hypersensitivity (allergic reactions).
Hypercalcemia (high blood levels of calcium).
Nausea and vomiting caused by chemotherapy.
Thrombocytopenia (low platelet levels).
Prednisone is also used alone or with other drugs to treat many other diseases and conditions. The drug continues to be studied in the treatment of many types of cancer and other conditions.
I'm afraid that you may be right, a collaboration with big pharma is what is needed. With excellent new management taking over that becomes a real possibility. Dilution isn't the solution nor is another infusion from JW.
News 
Market Data 
Discover 
